CompletedNot Applicable

Prognostic Value of Finger Blood Pressure in Arteriovenous Fistula Care

Singapore20 participantsStarted 2019-08-05

Plain-language summary

The goal of this trial is to investigate the prognostic value of monitoring finger blood pressures (FBPs) in predicting the success of surgically created arteriovenous fistula (AVF) for patients with end stage renal disease. The main questions it aims to answer is: \- Can FBPs predict AVF maturation? Participants will undergo FBP measurements at pre-op, immediately post-op, 4 weeks and 6 weeks post-AVF creation.

Who can participate

Age range

21 Years – 90 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participants has documented Chronic Kidney Disease (CKD), determined by Glomerular Filtration Rate (GFR) * Participant is recommended for renal replacement therapy based on clinical assessment of renal function as well as CKD staging, as documented in clinical notes. * Haemodialysis was chosen as the most appropriate renal replacement therapy * Participant is able to consent to the creation of an AVF in preparation for hemodialysis. * Participant is able to adhere to follow-up assessments of AVF maturation, if applicable. Exclusion Criteria: * Subject had a previous AVF and is now undergoing surgery for another AVF creation * Subject has amputation distal to AVF * Subject is pregnant or planning to conceive * Participants is unable to consent

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Correlation between AVF maturation and changes in Finger Blood Pressure measurements at baseline and immediately post-op

Timeframe: Within 24 hours

Trial details

NCT IDNCT06765577

SponsorSingapore General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-12-27

View on ClinicalTrials.gov More End Stage Renal Disease trials